Picture your Future. Save for it by earning 1.5% on a 1-year Term Deposit Account! Learn more.

Epic Investment Partners Views: The Week Ahead

This week kicks-off with global manufacturing and services PMI data, and the Fed’s Bostic and BoE’s Bailey speak today. Germany IFO, and US new home sales and the conference Board consumer confidence prints are due on Tuesday. The Bao Forum, or “China’s Davos” takes place (Tue-Fri). Central bank chatter on Tuesday includes the Fed’s Williams and the ECB’s Vujcic and Holzmann. UK CPI and US durable goods garner interest on Wednesday. The UK Chancellor Reeves’ “Spring Statement” will be scrutinised, particularly given Reeves has warned that as many as 10,000 civil servants will be replaced with better use of tech including AI. We will also hear from the Fed’s Musalem and the ECB’s Cipollone. Revised US GDP, and initial jobless claims follow on Thursday. On a busy day for central bank speak, we will hear from the Fed’s Barkin, the BoE’s Dhingra and the ECB’s Guindos, Galhau, Wunsch, Escrivá and Schnabel. Eurozone consumer confidence, Japan CPI, UK GDP and retail sales and US income and spending, core PCE and Uni. of Michigan consumer sentiment will keep markets on their toes.  

Central banks were a key feature last week. The Fed held pat on rates, as expected while noting slightly higher inflation and weaker growth in its projections. Markets responded positively to Powell’s description of potential tariff-based inflation as “transitory,” interpreting this as flexibility to cut rates if needed despite inflation concerns. Additionally, the Fed announced it will dramatically slow its Treasury balance sheet reduction from USD25bn to USD5bn monthly.  

Later the Bank of Japan unanimously maintained its policy rate at 0.5%, with Governor Ueda providing cautious guidance without specifying the timing of the next rate hike. While emphasising uncertainties around US trade policy, the BoJ is closely monitoring inflation risks following strong preliminary Shunto wage negotiations that exceeded 5% growth, with upcoming April inflation data likely to influence the possibility of a May rate hike.  

The BoE also maintained its benchmark interest rate, at 4.5%, with an 8-1 majority vote, as the UK faces uncertainty around global trade and domestic economic stagnation. The central bank noted intensified global trade policy uncertainty and weakening economic indicators; while suggesting a “gradual and careful approach” to future monetary policy adjustments, balancing inflation concerns against growth risks in what appeared to be a more hawkish stance than expected. 

A mixed week for asset classes amid tariff rhetoric and potential 2 April reciprocal tariffs saw the yield on the 10-year UST rally 7bps to 4.25%, while the S&P Index gained 0.51%. The dollar also gained, the DXY Index closed 0.36% higher on the week. Oil enjoyed a 2.24% increase, to $72.16pb amid tighter supply. 

US data was once again largely mixed, empire manufacturing massively disappointed at -20, while retail sales were broadly softer-than-expected. The New York Fed services business activity print fell to -19.3 in March, the lowest level since early-2023. The Phili. Fed Business outlook was surprisingly strong, however, lower than the previous reading, and existing home sales also beat market expectations for a fall at +4.2%mom.  

Elsewhere, the People’s Bank of China’s Q1 monetary policy meeting emphasised reducing social financing costs, signalling intent to lower funding costs whilst favouring structural tools over broad-based easing. The PBoC plans to optimise re-lending mechanisms for technological innovation and explore new policy tools for investment, consumption, and trade stabilisation. At the start of this week’s China Development Forum, where the theme is “Unleashing Development Momentum for Stable Global Growth”, the nation’s Premier Li Qiang said China is prepared for “shocks that exceed expectations”. 


Epic Investment Partner’s Key risks & Disclaimers:

EPIC Global Equity Fund (the “Fund”) is a sub-fund of EPIC Funds p.l.c. (the “Company”), which is an open-ended umbrella fund authorised in Ireland as a UCITS fund and regulated by the Central Bank of Ireland. This marketing material has been approved in the UK by EPIC Markets (UK) LLP, trading as EPIC Investment Partners, which is a limited liability partnership incorporated and registered in England and Wales under partnership OC306260 with its registered office at Audrey House, 16-20 Ely Place, London EC1N 6SN. EPIC Markets (UK) LLP is regulated by the Financial Conduct Authority. Distribution of this material and the offer of the Fund are specifically restricted in certain jurisdictions. In particular, but without limitation, neither this material nor shares in the Fund are available to US persons.

This document is for general information purposes only and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. It is not a personal recommendation and it should not be regarded as a solicitation or an offer to buy or sell any shares in the Fund. This document represents the views of EPIC Investment Partners at the time of writing. It should not be construed as investment advice. Any person interested in investing in the Fund should conduct their own investigation and analysis of the Fund and should consult their own professional tax, accounting or other advisers as to the risks involved in making such an investment. Full details of the Fund’s investment objectives, investment policy and risks are set out in the Fund’s Prospectus and Supplement which, together with the Key Information Document (“KID”), are available on request and free of charge from Maples Fund Services (Ireland) Limited, 32 Molesworth Street, Dublin 2, Ireland and, in the UK, from EPIC Markets (UK) LLP, Audrey House, 16-20 Ely Place, London EC1N 6SN. Any offering of the Fund is only made on the terms of the current Prospectus, Supplement and KID. A subscription in the Fund can only be made after the provision of the KIID and should be made solely upon the information contained in the Prospectus, Supplement and KID.

An investment in the Fund is not suitable for an investor who cannot sustain a loss on their investment. There is no guarantee of the Fund’s future performance and past performance is not a reliable indicator of future performance. The value of your investment and the income derived from it can go down as well as up, and you may not get back the money you invested. The risks associated with making an investment in the Fund are described in the Prospectus and Supplement but investors should note, in particular, the following: 1) Foreign currency denominated investments are subject to fluctuations in exchange rates that could have a positive or an adverse effect on an investor’s returns. There is also a risk that currency hedging transactions for one share class may in extreme cases adversely affect the net asset value of the other share classes within the same sub-fund since there is no legal segregation between share classes; 2) The Fund is subject to the risk of the insolvency of its counterparties; and 3) Emerging market securities are subject to greater social, political, regulatory, and currency risks than developed market securities. This may impact the liquidity and value of such securities and, consequently, the value of the Fund.


MeDirect Disclaimers:

This information has been accurately reproduced, as received from EPIC Investment Partners. No information has been omitted which would render the reproduced information inaccurate or misleading. This information is being distributed by MeDirect Bank (Malta) plc to its customers. The information contained in this document is for general information purposes only and is not intended to provide legal or other professional advice nor does it commit MeDirect Bank (Malta) plc to any obligation whatsoever. The information available in this document is not intended to be a suggestion, recommendation or solicitation to buy, hold or sell, any securities and is not guaranteed as to accuracy or completeness.

The financial instruments discussed in the document is intended for retail clients however, it may not be suitable for all investors and investors must make their own informed decisions and seek their own advice regarding the appropriateness of investing in financial instruments or implementing strategies discussed herein.

If you invest in this product you may lose some or all of the money you invest. The value of your investment may go down as well as up. A commission or sales fee may be charged at the time of the initial purchase for an investment. Any income you get from this investment may go down as well as up. This product may be affected by changes in currency exchange rate movements thereby affecting your investment return therefrom. The performance figures quoted refer to the past and past performance is not a guarantee of future performance or a reliable guide to future performance. Any decision to invest in a mutual fund should always be based upon the details contained in the Prospectus and Key Information Document (KID), which may be obtained from MeDirect Bank (Malta) plc.

Join MeDirect today to access the tools you need to put your money to work on your own terms.

Latest news articles

When economic rules start to bind
All News

BlackRock Commentary: When economic rules start to bind

U.S. trade policy is accelerating a broader structural shift driven by mega forces like geopolitical fragmentation, making long-term market expectations more reactive to short-term developments, with AI emerging as a key long-term return driver—especially in the U.S.

Experience better Banking

The sooner you start managing your money, your way, using the best-in-class tools, the sooner you’ll see results. 


Sign up and open your account for free, within minutes.

MeDirect_Multi-Devices-cards

You are leaving medirect.com.mt

Please be aware that the external site policies, or those of another MeDirect website, may differ from this website’s terms and conditions and privacy policy. The next website will open in a new browser window or tab.

 

Note: MeDirect is not responsible for any content on third party sites, nor does a link suggest endorsement of those sites and/or their content.

Login

We strive to ensure a streamlined account opening process, via a structured and clear set of requirements and personalised assistance during the initial communication stages. If you are interested in opening a corporate account with MeDirect, please complete an Account Opening Information Questionnaire and send it to corporate@medirect.com.mt.

For a comprehensive list of documentation required to open a corporate account please contact us by email at corporate@medirect.com.mt or by phone on (+356) 2557 4444.